Proteome Sciences PLC
20 April 2000
Proteome Sciences ('the Company' or 'Proteome')
Proteome announces the result of the vote on the resolutions proposed at
today's Extraordinary General Meeting, held in connection with the Placing and
the Open Offer described in the Company's prospectus dated 28 March 2000.
The special resolution 1 was duly passed and, accordingly, the authorised
share capital of the Company has been increased from £3,000,000 to £3,200,000.
Furthermore the directors have been generally and unconditionally authorised
to allot Ordinary Shares in connection with the Placing and the Open Offer
having an aggregate nominal amount of £139,774.11 and to make such allotments
on a non pre-emptive basis.
The ordinary resolution 2 was duly passed and, accordingly, the directors have
been generally and unconditionally authorised to allot Ordinary Shares up to
an aggregate nominal amount of £318,602.56 until the expiry of five years from
the passing of the resolution.
The special resolution 3 was duly passed and, accordingly, the directors have
been authorised to allot securities of the Company for cash on a non
premeptive basis up to an aggregate nominal amount of £47,790.38 and as
detailed in the notice convening the EGM.
The ordinary resolution 4 was duly passed and, accordingly, the directors have
been authorised to grant options to R. Stephen Harris, Professor William
Dawson and Professor Keith Mansford.
The Placing and Open Offer remain conditional upon admission of the new
Ordinary Shares to trading on AIM.
The new Ordinary Shares to be allotted pursuant to the Placing and the Open
Offer are expected to commence trading on AIM at 8.30 a.m. on 25 April 2000.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.